PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Eurofins Ingenasa, Madrid, Spain. Electronic address: afresco@ingenasa.com.\', \'Eurofins Ingenasa, Madrid, Spain.\', \'Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam Institute on Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.\', \'Austrian Agency for Health and Food Safety, Department of Serology and Virology, Mödling, Austria.\', \'The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tummor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain; Emergency Department and Emergent Pathology Research Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.\', \'Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0732-8893(22)00018-910.1016/j.diagmicrobio.2022.115650
?:doi
?:hasPublicationType
?:journal
  • Diagnostic microbiology and infectious disease
is ?:pmid of
?:pmid
?:pmid
  • 35218991
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.157
?:rankingScore_hIndex
  • 86
?:title
  • Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all